Virtual Tour
Media
NEWS
Contact Us
Patients
Neurology & Ophthalmology
CinnoVex
ReciGen
CinnoTec
Ablyze
Xacrel
TYALIa
Cinnomer
Oncology & Hematology
PegaGen
CinnaPoietin
ZakAria
KidiPeg
Endocrinology & Hormone
Cinnal-f
CinnaFact
CinnaTropin
Melitide
Autoimmune & Immunology
CinnoPar
Zerafil
SpikoGen
CinnoRA
Healthcare Professionals
Neurology & Ophthalmology
CinnoVex
ReciGen
Cinnomer
Xacrel
Ablyze
TYALIa
CinnoTec
Oncology & Hematology
PegaGen
CinnaPoietin
KidiPeg
ZakAria
Endocrinology & Hormone
Cinnal-f
CinnaTropin
CinnaFact
Melitide
Autoimmune & Immunology
CinnoRA
CinnoPar
Zerafil
SpikoGen
Capabilities
Our Technology
Business Development
Our Manufacturing Sites
Research and Development
About Us
Presidential Note
About CinnaGen
Mission Statement
Policy
Management Team
Search
Virtual Tour
Media
NEWS
Contact Us
News
2018
CinnaGen Sponsors IranPharma Expo
23Sept. 2018
CinnaGen Co. is sponsoring IRANPHARMA EXPO, taking place at the Grand Musalla in Tehran.
CinnaGen in Iraq Health care Exhibition
28June 2018
CinnaGen participated in the Iraq Health Exhibition in Baghdad from June 28th to June 30th, 2018.
CinnaGen obtained a Halal Certificate
30May 2018
A first in the pharmaceutical industry for biologicals; CinnaGen has succeeded in obtaining a Halal certificate for its medicinal products.
Cinnagen in Duphat
03Mar. 2018
CinnaGen recently participated in Duphat, the biggest pharmaceutical event in the MENA region.
CinnaGen obtained GMP certification from EMA
24Feb. 2018
Iranian biosimilar company CinnaGen obtained GMP certification from EMA
Home
News: 2018
Back top Top